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  Adhesion  through  microbial  surface  components  that 
recognize adhesive matrix molecules is an essential step in 
infection for most pathogenic bacteria. In this study, we 
report that LigB interacts with fibronectin (Fn) through 
its variable region. A possible role for LigB in bacterial at-
tachment to host cells during the course of infection is sup-
ported  by  the  following  observations:  (i)  binding  of  the 
variable  region  of  LigB  to  Madin-Darby  canine  kidney 
(MDCK) cells in a dose-dependent manner reduces the ad-
hesion of Leptospira, (ii) inhibition of leptospiral attach-
ment to Fn by the variable region of LigB, and (iii) de-
crease  in  binding  of  the  variable  region  of  LigB  to  the 
MDCK cells in the presence of Fn. Furthermore, we found 
a significant reduction in binding of the variable region of 
LigB to Fn using small interfering RNA (siRNA). Finally, 
the isothermal titration calorimetric results confirmed the 
interaction between the variable region of LigB and Fn. 
This is the first report to demonstrate that LigB binds to 
MDCK cells. In addition, the reduction of Fn expression in 
the MDCK cells, by siRNA, reduced the binding of LigB. 
Taken together, the data from the present study showed 
that LigB is a Fn-binding protein of pathogenic Leptospira 
spp. and may play a pivotal role in Leptospira-host inter-
action during the initial stage of infection.
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Introduction 
  Leptospirosis is a zoonotic disease caused by pathogenic 
spirochetes in the genus Leptospira [22]. The disease oc-
curs widely in developing countries and is reemerging in 
the United States [29]. The clinical features are variable 
and include subclinical infection, a self-limited anicteric 
febrile illness and severe, potentially fatal disease [22]. In 
the severe form of leptospirosis (Weil's syndrome), the 
symptoms include an acute febrile illness associated with 
multi-organ damage with liver failure (jaundice), renal 
failure (nephritis), pulmonary hemorrhage, and meningitis 
[10]. If not treated, the mortality rate may exceed 15% [49]. 
Furthermore, Leptospira infection can trigger autoimmune 
diseases in horses as well as humans [36,41]. Several fac-
tors associated with virulence have been proposed for 
Leptospira spp., including the sphingomyelinases, serine 
proteases, zinc-dependent proteases, collagenase [3], 
LipL32 [59], the novel factor H-binding protein LfhA [54], 
and lipopolysaccarides [56]. 
  Pathogenic spirochetes have evolved a variety of strat-
egies to infect host cells such as evasion of the innate as 
well as adaptive immunity [54]. Attachment to host cells is 
an essential step for colonization by bacterial pathogens. 
Leptospira has been shown to bind to mammalian cells, 
such as Madin-Darby canine kidney (MDCK) cells [2] via 
the extracellular matrix (ECM) [15]. Several adhesion 
molecules in the pathogenic spirochetes have been identi-
fied including a Fn binding protein (36 kDa protein) [30], 
a laminin binding protein (Lsa24) [1], and Lig proteins 
[25,33,34] from Leptospira spp., decorin-binding proteins 
(Dbp A and B) [37] and Fn-binding proteins (BBK 32 and 
47 kDa) [21,38] from Borrelia spp. and MSP, Tp0155, 
Tp0483, Tp0751 from Treponema spp. [4,5,9]. Lig pro-
teins (Lig A, B and C) possess immunoglobulin-like do-
mains with 90 amino acid repeats that have been identified 
in other adhesion molecules, such as the intimin of 
Escherichia coli and the invasin of Yersinia pseudotu-
berculosis [14,17]. Interestingly, the N-terminal 630 ami-
no acid sequences of LigA and B are identical, but the 
C-terminal amino acid sequences are variable with only 
34% identitify [33]. ligB  also encodes a C-terminal, 
non-repeat domain of 771 amino acid residues [33]. On the 
other hand, the ligA-ligB intergenic regions from L. kirsch-
neri and L. interrogans are 943 bp and 1347 bp in length re-
spectively, and ligC is not linked to the ligA-ligB locus 
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key environmental signal, osmolarity, to enhance the bind-
ing of Leptospira to host cells [26,27].
    It has been shown that the lig  genes are present ex-
clusively in pathogenic Leptospira spp [25,33]. LigA and 
LigB are weakly expressed in low passage, but not in high 
passage cultures of this organism [25,33]. Importantly, we 
have shown that LigA and LigB expression is upregulated 
in vivo in the kidneys of Leptospira-infected hamsters [34]. 
Recently, LigA and LigB have been reported to bind to ex-
tracellular matrix proteins including collagens type I and 
IV, laminin, fibronectin, and fibrinogen [6,24]. These data 
indicate that Lig proteins may play an important role in at-
tachment of pathogenic leptospires to host cells. 
  Although there are three copies of lig genes (ligA, B and 
C) in L. interrogans serovar Pomona and L. interrogans se-
rovar Copenhageni [31,33,34], only ligB is present in most 
pathogenic Leptospira spp. ligA is absent in L. interrogans 
serovar Lai [42], ligC is truncated (a pseudogene) in L. 
kirschneri serovar Grippotyphosa [25] and both ligA and 
ligC are absent in L. borgpetersenii serovar Harjo [3]. 
Therefore, we focused on LigB in this study and report that 
the variable region of LigB binds with high affinity to Fn, 
suggesting that this fragment is crucial for bacterial adhe-
sion to host cells.
Materials and Methods 
Bacterial strains and cell culture 
  L. interrogans serovar Pomona (NVSL1427-35-093002) 
was used in this study [35]. All experiments were per-
formed with virulent, low-passage strains obtained by in-
fecting golden syrian hamsters as previously described 
[35]. Leptospires were grown in EMJH medium at 30
oC for 
less than 5 passages and growth was monitored by dark- 
field microscopy. The MDCK cells (ATCC CCL34) were 
cultured in Dulbecco minimum essential medium contain-
ing 10% fetal bovine serum (GIBCO, USA) and were 
grown at 37
oC in a humidified atmosphere with 5% CO2. 
Reagents and antibodies 
  Horseradish  peroxidase  (HRP)-conjugated goat anti- 
hamster antibody, HRP-conjugated goat anti-mouse anti-
body and HRP-conjugated goat anti-rabbit antibody were 
purchased from Zymed (USA). Rabbit anti-glutathione 
S-transferase (GST) antibody, Alexa 594-conjugated goat 
anti-hamster antibody, Alexa 488-conjugated goat an-
ti-hamster antibody, and FITC-conjugated goat anti-mouse 
antibody were purchased from Molecular Probe (USA). 
Anti-Fn (MAB1932) and anti-actin mouse antibodies 
(MAB1501) were purchased from Chemicon International 
(USA). Human plasma Fn was purchased from GIBCO 
(USA). Anti-L. interrogans antibodies were prepared in 
hamsters as previously described [35]. 
Plasmid construction and protein purification 
  Constructs for the expression of GST, GST fused with the 
conserved region of LigB (LigBCon; amino acids 1-630) 
and GST fused with the central variable region of LigB 
(LigBCen; amino acids 631-1417) were previously gen-
erated using the vector pGEX-4T-2 (Amersham Pharmacia 
Biotech, USA) [33]. GST fused with the C-terminal varia-
ble region of LigB (LigBCtv; amino acids 1418-1889) was 
generated using the vector pET41A (Novogen, USA). 
Relevant fragments of DNA were amplified by PCR using 
primers based on the ligB sequence [33]. Primers were de-
signed to introduce a SalI site at the 5' end of each fragment 
and a stop codon followed by a NotI site at the 3' end of 
each fragment. The PCR products were digested sequen-
tially with SalI and NotI and then ligated into pGEX-4T-2 
or pET41A cut with SalI and NotI. We purified the soluble 
form of GST-LigBCon, GST-LigBCen and GST-LigBCtv 
from E. coli as previously described [34,35]. 
Binding assays by ELISA 
  To measure the binding of Leptospira to the ECM compo-
nents, 1 mg of each ECM component (as indicated in Fig. 
1A) in 100 μl PBS (pH 7.2) was coated onto microtiter 
plate wells. For the dose-dependent binding experiments, 
different concentrations of Fn (as indicated in Fig. 1B) 
were coated onto the microtiter plate wells. The plates were 
incubated at 4
oC for 16 h and subsequently blocked with 
blocking buffer (50 μl/well) containing 3.5% BSA in 50 
mM Tris (pH 7.5)-100 mM NaCl-1 mM MgCl2, MnCl2, 
and CaCl2 at room temperature (RT) for 2 h. Then, the 
Leptospira (10
7) were added to each well and further in-
cubated at 37
oC for 6 h. To determine the inhibition of 
Leptospira binding to the MDCK cells by Fn, the Leptospi-
ra (10
7) were pre-incubated at 37
oC for 1 h with various 
concentrations of Fn (as indicated in Fig. 1C) prior to the 
addition of the MDCK cells (10
5) and finally incubated for 
6 h at 37
oC. The percentage of adhesions was determined 
relative to the attachment of the untreated Leptospira bind-
ing to the MDCK cells. For all experiments, the same con-
centration of BSA was used as a negative control. To de-
termine the binding of LigBCen or LigBCtv to Fn, 10 nM 
of GST-LigBCen, GST-LigBCtv or GST (negative con-
trol) was added to 96 well microtiter plates coated with var-
ious concentrations of Fn (as indicated in Fig. 3A) or BSA 
(negative control and data not shown) in 100 μl PBS for 1 
h at 37
oC. 
  To measure the binding inhibition of Leptospira to Fn, 
various concentrations of GST-LigBCen, GST-LigBCtv 
(as indicated in Fig. 3B) or GST (negative control) in 100 
μl PBS was added to Fn or BSA (negative control and data 
not shown) (1 mg in 100 μl PBS) coated wells at 37
oC for 
1 h, then the Leptospira (10
7) were added to each well and 
incubated at 37
oC for 6 h. To measure the binding of 
LigBCen or LigBCtv to the MDCK cells, the MDCK cells LigB-Fn interaction mediates cell adhesion    135
Fig. 1. The binding of L. interrogans serovar Pomona (NVSL 1427-35-093002) to Fn (A). Binding of Leptopsira to various 
immobilized ECM components. Leptospira (10
7) were added to wells coated with each ECM (1 mg in 100 μl PBS) including Fn, 
chondroitin-6-sulfate (C6S), chondroitin sulfate A (CSA), chondroitin sulfate B (CSB), gelatin A (GA), gelatin B (GB), heparin (HP),
keratin (KR), or BSA (negative control). (B). Binding of Leptospira (10
7) to various concentrations of Fn (0, 10, 20, 100 or 1,000 μg
in 100 μl PBS). BSA served as a negative control. (C). Fn inhibits the binding of Leptospira to the MDCK cells. Leptospira (10
7) were
treated with various concentrations of Fn (0, 0.01, 0.1, 0.2, 1, 2, or 10 μg) or BSA (negative control) prior to addition to the MDCK cells
(10
5). The percentage adhesion was determined relative to the attachment of untreated Leptospira onto the MDCK cells. (D). Binding
of Leptospira to immobilize Fn. Leptospira (10
8) were cultured in Fn or BSA (negative control) coated (1 mg in 100 μl PBS) or 
un-coated wells (negative control). (E). Fn inhibited the binding of Leptospira to the MDCK cells. Leptospira (10
8) were pre-treated 
with 10 μg of Fn or BSA (negative control) prior to addition to the MDCK cells (10
6). Un-treated Leptospira was used as a negative 
control. The binding of Leptospira to ECMs or Fn or the adhesion of Leptospira to the MDCK cells was measured by ELISA (A, B, 
and C) or EPM (D and E). For all experiments, each value represents the mean ± SE of three trials performed in triplicate samples. 
Statistically significant (p ＜ 0.05) differences are indicted by an asterisk. The EPM settings were identical for all captured images (D
and E).
(10
5) were incubated with various concentrations (as in-
dicated in Fig. 4A) of GST-LigBCen, GST-LigBCtv or 
GST (negative control) in 100 μl PBS for 1 h at 37
oC. To 
measure the binding inhibition of Leptospira to the MDCK 
cells treated with LigBCen or LigBCtv, the MDCK cells 
(10
5) were pretreated with various concentrations (as in-
dicated in Fig. 4B) of GST-LigBCen, GST-LigBCtv or 
GST (negative control) in 100 μl PBS for 1 h at 37
oC. 
Then, the Leptospira (10
7) were added to each well and in-
cubated for 6 h at 37
oC. Following the incubation, the 
plates were washed three times with phosphate-buffered 
saline (PBS) containing 0.05% Tween-20 (PBST). To 
measure the binding of the Leptospira, hamster anti- 
Leptospira (1：200) and HRP-conjugated goat anti-ham-
ster IgG (1：1,000) were used as primary and secondary 
antibodies, respectively. To detect the binding of GST- 136    Yi-Pin Lin et al
Fig. 2. The interaction between LigB and Fn by the GST-pull 
down assay (A) A schematic diagram showing the structure of 
LigB and the truncated LigB protein used in this study. (B). 
Human plasma Fn ( lane 2 to lane 5 ) or cell lysates of the MDCK
cells (lane 7 to lane 10) was applied to the GST beads pre-
immobilized by GST, GST-LigBCon, GST-LigBCen, or GST- 
LigBCtv at 4
oC for 3 h. The pull down complex was analyzed by
immunoblot analysis using Fn antibodies. Lane 1 and lane 6 
contain 1 μg of human plasma Fn and the cell lysate from 1 × 10
6
MDCK cells, respectively, to serve as a positive reference. Lane 
2 and lane 7 are GST-LigBCen, lane 3 and lane 8 are GST- 
LigBCtv, lane 4 and lane 9 are GST-LigBCon, and lane 5 and lane
10 are GST. The molecular mass of the human Fn and canine Fn
(MDCK cells) was 261 kDa and 271 kDa, respectively, and the 
relative positions of the standards are given in kDa on the left.
LigBCen, GST-LigBCtv, or GST to Fn or the MDCK cells, 
rabbit anti-GST (1：200) and HRP-conjugated goat an-
ti-rabbit IgG (1：1,000) were used as primary and secon-
dary antibodies, respectively. After washing the plates 
three times with PBST, 100 μl of TMB (KPL, USA) was 
added to each well and incubated for 5 min. The reaction 
was stopped by adding 100 μl of 0.5% hydrofluoric acid in 
each well. Each plate was read at 630 nm by an ELISA 
plate reader (Bioteck EL-312; BioTeck, USA). Each value 
represents the mean  ±  standard error of the mean (SEM) 
of three trials performed in triplicate samples. Statistically 
significant (p ＜ 0.05) differences are indicated by asterisks. 
Binding assays by epifluorescence microscopy (EPM) 
and confocal laser-scanning microscopy (CLSM) 
  To measure the binding of Leptospira to Fn by EPM, 
Leptospira (10
8) were added to each well (eight well cul-
ture slides) coated with 1 mg Fn or BSA (negative control) 
in 100 μl of PBS and incubated at 37
oC for 6 h (Fig. 1D). 
To measure the binding inhibition of Leptospira to the 
MDCK cells by Fn, 10
8 Leptospira were pre-incubated 
with 10 μg of Fn or BSA (negative control) in 100 μl of 
PBS for 1 h at 37
oC prior to the addition of 10
6 MDCK cells 
and incubated 6 h at 37
oC (Fig. 1E). To measure the binding 
inhibition Leptospira to Fn by LigBCen or LigBCtv by 
EPM, 50 nM of GST-LigBCen, GST-LigBCtv or GST 
(negative control) in 100 μl PBS was added to each of the 
Fn or BSA (negative control and data not shown) (1 mg per 
100 μl) coated wells for 1 h at 37
oC. Then, the Leptospira 
(10
8) were added to each well and incubated for 6 h at 37
oC 
(Fig. 3C). To determine the binding inhibition of Leptospi-
ra to the MDCK cells by LigBCen or LigBCtv by CLSM, 
the MDCK cells (10
6) were preincubated with 50 nM of 
GST-LigBCen, GST-LigBCtv or GST (negative control) in 
100 μl of PBS for 1 h at 37
oC respectively. Then, the 
Leptospira (10
8) were added to each well and incubated for 
6 h at 37
oC (Fig. 4C). For the detection of Leptospira bind-
ing in Figs. 1D, E, and Fig. 3C, hamster anti-Leptospira an-
tibodies (1：100) and Alexa 488-conjugated goat an-
ti-hamster IgG (1：250) were used as primary and secon-
dary antibodies, respectively. To determine the attachment 
of Leptospira and the binding of GST-LigBCen, GST- 
LigBCtv or GST, Fig. 4C, rabbit anti-GST (1：250) and 
hamster anti-Leptospira antibodies (1：100) served as pri-
mary antibodies, and FITC conjugated goat anti-rabbit IgG 
(1：250) and Alexa 594-conjugated goat anti-hamster IgG 
(1：250) were used as secondary antibodies. Fixation and 
immunofluorescence staining were performed as pre-
viously described [44] with slight modifications. Briefly, 
Leptopsira and the MDCK cells were fixed in 2% paraf-
ormaldehyde for 60 min at RT. For the antibody labeling, 
fixed bacteria were incubated in PBS containing 0.3% 
BSA for 10 min at RT. The primary and secondary anti-
bodies, in the PBS containing 0.3% BSA, were incubated 
sequentially for 60 min at RT. After incubation with the pri-
mary and secondary antibodies, the glass slides were 
mounted with coverslips using Prolong Antifade (Molecu-
lar Probe, USA) and viewed with a 60 × objective by EPM 
(Nikon, Japan) or CLSM (Olympus, Japan). An Olympus 
Fluoview 500 confocal laser-scanning imaging system, 
equipped with krypton, argon and He-Ne lasers on an 
Olympus IX70 inverted microscope with a PLAPO 60 × 
objective, was used. The settings were identical for all cap-
tured images. Images were processed using Adobe 
Photoshop CS2. For counting the attachment of Leptospira 
to the MDCK cells or Fn, three fields were selected to 
count the number of binding organisms. All studies were 
repeated three times and the number of Leptospira attached 
to the MDCK cells were counted by an investigator blinded 
to the treatment group. 
GST pulldown assay 
  The GST pull-down assay was performed as previously 
described [57]. Purified proteins or GST (negative control) 
were loaded onto 0.5 ml glutathione-Sepharose beads LigB-Fn interaction mediates cell adhesion    137
Fig. 3. LigBCen or LigBCtv binds to Fn and inhibits the binding of Leptospira to Fn (A). Binding of LigBCen or LigBCtv to various
concentrations of immobilized Fn. Ten nM of GST-LigBCen, GST-LigBCtv or GST (negative control) was added to wells coated with
various concentrations of Fn (0, 0.27 μM, 0.45 μM, 2.7 μM, 4.5 μM, 27 μM, or 45 μM) in 100 μl PBS. The binding of each of these
proteins to Fn was measured by ELISA. (B) LigBCen or LigBCtv inhibited the binding of Leptospira to immobilized Fn. Various 
concentrations (0, 2, 4, 6, or 8 nM) of GST-LigBCen, GST-LigBCtv, or GST (negative control) were added to each well coated with Fn
(1 mg in 100 μl PBS) prior to the addition of Leptospira (107). The attachment of Leptopsira to wells was measured by ELISA. The 
percentage of attachment was determined relative to the attachment of Leptopsira in the untreated Fn. (C) LigBCen or LigBCtv 
inhibited the binding of Leptospira to Fn. Fifty nM of GST-LigBCen, GST-LigBCtv or GST (negative control) was added to wells 
coated with Fn (1 mg in 100 μl PBS) prior to the addition of Leptospira (10
8). The binding of Leptospira to wells was detected by EPM.
In (A) and (B), each value represents the mean ± SE of three trials performed in triplicate samples. Statistically significant differences
(p ＜ 0.05) are indicted by *. In (C), The EPM settings were identical for all captured images. Images were processed using Adobe 
Photoshop CS2.
Fig. 4. Isothermal titration calorimetry (ITC) profile of LigBCtv with Fn as a typical ITC profile in this studyA: heat differences obtained
from 25 injections. B: Integrated curve with experimental point (򰇮) and the best fit (−). The thermodynamic parameters are shown
in Table 1.138    Yi-Pin Lin et al
Table 1. Thermodynamic parameters for the interaction of Fn and truncated LigB
Macromolecule LigB Residues [Macromolecule] [Fn] ΔH ΔSK d
μM μM kcal mol
−1 cal mol
−1 K
−1 μM
LigBCon 1-630 1.25 25 n/f* n/f* n/f*
LigBCen 631-1,417 2 40 −2,002.67 ± 14   −6.68 0.011 ± 0.003
LigBCtv 1,418-1,889 2.82 56.4 −12,140 ± 557 −40.71 8.55 ± 0.75
*n/f: non-fittable.
(Amersham Biosciences Piscataway, USA) at 4
oC over-
night. The beads were then washed three times with the ly-
sis buffer containing 30 mM Tris acetate, 10 mM sodium 
phosphate, pH 7.4, 0.1% Tween 20, 1 mM EDTA, 2 μg/ml 
leupeptin, 4 μg/ml aprotinin, 1 μg/ml pepstatin A, and 1 
mM phenylmethylsulfonyl fluoride (PMSF). The MDCK 
cells (10
6) were lysed in the lysis buffer and used immedi-
ately after lysis. A 500 μl aliquot of cell lysate or human 
plasma Fn (40 μg/ml) was incubated with purified pro-
teins immobilized on glutathione-Sepharose beads at 4
oC 
for 3 h. After incubation, the beads were separated by cen-
trifugation, washed three times with the lysis buffer and 
boiled in Laemmli sample loading buffer consisting of 50 
mM Tris-HCl (pH 6.8), 100 mM dithiothreitol, 2% sodium 
dodecyl sulfate, 0.25 mM PMSF, and 0.1% bromophenol 
blue in 20% glycerol. The eluted proteins were subjected to 
6% SDS-PAGE and electroblotted onto polyvinylidene di-
fluoride membranes. The membranes were incubated in 
5% skim milk in PBS/T overnight and then incubated with 
mouse anti-Fn antibody (1：1,000). The immunocom-
plexes were detected with an HRP-conjugated goat an-
ti-mouse IgG antibody (1：5,000). 
Small interfering RNA (siRNA) inhibition of LigB 
binding 
  The siRNA duplexes directed against the sequence 5'- 
gcagcacaacuuccaauua-3' of Fn and negative siRNA du-
plex, 5'-auucuaucacuagcgugac-3', were selected by the 
software, siDESIGN [43] and synthesized by Dharmacon 
(USA). The RNA duplexes were introduced into the 
MDCK cells by the method of lipofection [18], and 8 × 10
5 
cells were transfected with 0.4 μg negative siRNA and 
Fn-siRNA. Adhesion assays were performed 72 h after lip-
ofection [51]. The knockdown efficiency of endogeneous 
Fn expression was determined as previously described [57] 
with slight modification. The total protein contents of the 
MDCK cells (10
6) were analyzed using Western immuno-
blotting as described under 'GST pulldown assays'. The 
protein bands of actin derived from the MDCK cells were 
measured as a control using a mouse anti-actin antibody 
(1：5,000). The band intensity was measured by densi-
tometry using the Image J software (National Institutes of 
Health, Bethesda, MD, USA) [53]. A LigB binding assay 
was performed 72 h after lipofection. To determine the 
binding of LigB fragments to Fn, each fragment (50 nM) 
was added to the MDCK cells (10
6) transfected with Fn or 
negative siRNA. To determine the binding of each frag-
ment and the expression of Fn in the MDCK cells, rabbit 
anti-GST (1：250) and mouse anti-Fn (1：250) served as 
the primary antibodies, and FITC-conjugated goat an-
ti-mouse IgG (1：250) and Texas Red-conjugated goat an-
ti-rabbit IgG (1：250) were used as secondary antibodies. 
Fixation, immunofluorescence staining, image detection, 
and processing were carried out as described in previous 
sections. All experiments were performed in triplicate.
Isothermal titration calorimetry 
  The experiments were carried out with CSC 5300 micro-
calorimeter (Calorimetry Science, USA) at 25
oC as pre-
viously described [47]. In a typical experiment, the cell 
contained 1 ml of a solution of proteins, and the syringe 
contained 250 μl of a solution of Fn at a concentration that 
was 20 times higher than the protein concentration in the 
cell. Both solutions were in PBS pH 7.5. The titration was 
performed as follows: 15 to 25 injections of 10 μl (Table 1) 
with a stirring speed of 250 rpm, and the delay time be-
tween the injections was 5 min. Data were analyzed using 
Titration BindingWork 3.1 software (Calorimetry Science, 
USA) that was fit to an independent binding model. The 
concentration of Fn and LigB used in this study was based 
on our preliminary titration experiments (data not shown).
Statistical analysis 
    Statistically significant differences between samples 
were determined using the Student's t-test following loga-
rithmic transformation of the data. Two-tailed p-values 
were determined for each sample, and a p ＜ 0.05 was con-
sidered significant. Each data point represents the mean ± 
SE of a sample tested in triplicate. An asterisk indicates 
that the result was statistically significant. 
Results 
Attachment of Leptospira to the MDCK cells was 
mediated by fibronectin 
  The binding of leptospiral cells to various ECM compo-LigB-Fn interaction mediates cell adhesion    139
Fig. 5. The binding of LigBCen or LigBCtv to the MDCK cells reduced leptospiral adhesion (A) Binding of LigBCen or LigBCtv to 
the MDCK cells. Various concentrations (0, 2, 4, 6, or 8 nM) of GST-LigBCen, GST-LigBCtv or GST (negative control) was added to
the MDCK cells (10
5). The binding of each of these proteins to the MDCK cells were measured by ELISA. (B) LigBCen or LigBCtv
inhibits the binding of Leptopsira to MDCK cells. The MDCK cells were incubated with various concentrations (0, 2, 4, 6, or 8 nM)
of GST-LigBCen, GST-LigBCtv or GST (negative control) prior to the addition of Leptopsira (10
7). The adhesion of Leptospira to the
MDCK cells (105) was detected by ELISA. The reduced percentage of attachment was determined relative to the attachment of 
Leptopsira in the untreated MDCK cells. (C). LigBCen or LigBCtv inhibited the binding of Leptopsira to the MDCK cells. The MDCK
cells (10
6) were pre-treated with 50nM of GST-LigBCen, GST-LigBCtv and GST (negative control) prior to the addition of the 
Leptopsira (10
8). The adhesion of Leptospira or the binding of these proteins to the MDCK cells were detected by CLSM. In (A) and
(B), each value represents the mean± SEM of three trials in triplicate samples. Statistically significant values (p ＜ 0.05) are indicted 
by *. In (C), the CLSM settings were identical for all the captured images. Images were processed using Adobe Photoshop CS2. 
nents was determined by ELISA. As shown in Fig. 1A, 
Leptospira were strongly bound to Fn, but not to other 
ECM molecules (Fig. 1A). Furthermore, the binding of 
Leptospira to Fn was dose dependent (Fig. 1B). When 
Leptospira were pretreated with Fn, binding to the MDCK 
cells was decreased (Fig. 1C). There was an approximately 
3.5-fold increase in the immobilization of Leptospira in the 
Fn-coated wells compared to the controls (Fig. 1D). More-
over, Fn was observed to block the attachment of Leptospi-
ra, by approximately 47%, when the Fn treated Leptospira 
were added to the MDCK cells (Fig. 1E). Thus, Fn appears 
to mediate the attachment of Leptospira to the MDCK 
cells.
Interaction between LigB and Fn 
  To determine whether LigB interacts with Fn, we trun-
cated the LigB protein into three parts, LigBCon, LigBCen 
and LigBCtv, (Fig. 2A) due to the difficulty of expressing 
and purifying the full length LigB [33]. First, we analyzed 
the interaction of each LigB fragment with Fn using a 
GST-pull down assay. Our results showed that both human 
plasma Fn and Fn derived from the MDCK cell lysates 
could bind both LigBCen and LigBCtv, but not LigBCon 
(Figs. 2B and C). Since LigBCen and LigBCtv showed a 
positive pull down result, the interaction between LigBCen 
and LigBCtv with Fn was further studied by ELISA. We 
found that both the binding of LigBCen and LigBCtv to Fn, 140    Yi-Pin Lin et al
Fig. 6. The binding of LigBCen or LigBCtv to Fn siRNA 
transfected MDCK cells was reduced (A). Detection of the 
expression of Fn and actin in the MDCK cells 72 h after 
transfected by Fn or negative siRNA. Fn and α-actin were 
detected by immunoblotting probed by actin antibody or Fn 
antibody. (B) Binding of GST-LigBCen or (C) GST-LigBCtv 
was reduced by the siRNA transfected cells. (D) GST served as a
negative control. Fifty nM of GST-LigBCen, GST-LigBCtv or 
GST was added to Fn or the negative siRNA transfected MDCK
cells. Expression of Fn and the binding of these proteins to the 
MDCK cells were detected by CLSM. The CLSM settings were
identical for all the captured images. Images were processed 
using Adobe Photoshop CS2. 
and the inhibition of the attachment of Leptospira to Fn by 
LigBCen and LigBCtv, were dose-dependent (Figs. 3A 
and B). Moreover, the EPM images revealed an up to 40% 
reduction in the attachment of Leptospira to Fn in the pres-
ence of LigBCen and LigBCtv (Fig. 3C). Finally, in order 
to quantitatively evaluate the binding affinity between Fn 
and LigB fragments, the dissociation constants (Kd) were 
measured by ITC (Table 1). Fig. 4 shows the data from a 
typical ITC experiment. The interaction appears to be exo-
thermic with a favorable enthalpy and unfavorable 
entropy. The calculated Kd values for Fn binding to 
LigBCen and LigBCtv were 0.01 μM and 8.55 μM, re-
spectively (Table 1). The binding of LigBCon could not be 
detected by ITC (data not shown). These findings are in 
agreement with our previous results. Altogether, these data 
indicate that Fn specifically interacts with LigBCen and 
LigBCtv fragments.
LigBCen and LigBCtv mediate the attachment of 
Leptospira to the MDCK cells 
  To determine if LigB is used by Leptospira to adhere to 
the MDCK cells, various concentrations of LigBCen or 
LigBCtv were added to the MDCK cells, and binding was 
detected by ELISA and immunofluorescence staining. Our 
results clearly showed that LigBCen and LigBCtv were 
bound to the MDCK cells in a dose dependent manner (Fig. 
5A). Pretreatment of the MDCK cells with LigBCen or 
LigBCtv reduced the attachment of Leptospira by ∼32%. 
The reduction of Leptospira attachment was also dose-de-
pendent (Figs. 5B and C). We further elucidated the re-
ceptor role of Fn in the MDCK cells for its possible ligand, 
LigB on the surface of Leptospira, by RNA interference to 
decrease the endogeneous Fn expression in the MDCK 
cells. As shown in Fig. 6A, transfection of the cells with 
siRNA duplex specific for canine Fn resulted in a ∼36% 
reduction of the Fn expression, relative to the control cells. 
The binding of LigBCen and LigBCtv to Fn siRNA-trans-
fected MDCK cells was significantly reduced (Figs. 6B 
and C). These results suggest that Fn serves as a receptor 
for LigB that mediates Leptospira adhesion.
Discussion
  Adhesion to host cells is pivotal for many pathogenic bac-
teria including Leptospira spp. Since pathogenic Leptospi-
ra spp. can infect a variety of tissues including liver, kidney 
and lung, study of the host-pathogen interaction is ex-
tremely important for improved understanding of lepto-
spirosis. Recently, the leptospiral genome has been se-
quenced and a number of tentative virulence factors have 
been proposed [3,31,42]. However, their exact roles in lep-
tospiral pathogenesis remain to be established. To date, 
several leptospiral adhesion molecules have been identi-
fied. These include a 36 kDa Fn-binding protein [30], a 24 LigB-Fn interaction mediates cell adhesion    141
kDa laminin-binding protein [1] and LigA, LigB and LigC 
proteins [25,33,34]. These molecules may play an im-
portant role in the pathogenesis of leptospiral infection 
since they are able to bind to ECMs such as collagens I and 
IV, laminin and fibronectin [6,24]. 
  Pathogenic Leptospira spp. have been previously reported 
to adhere to extracellular matrices [15,16] including Fn. 
Fns are dimers of two similar peptides linked at their C-ter-
mini by two disulfide bonds [8] and serve as receptors for 
several bacteria, including spirochetes [7,11,12,19,20, 
23,28,32,38,40,46,50,55]. Our results showed that Fn im-
mobilized Leptospira. In addition, Fn was observed to 
block the attachment of Leptospira to MDCK cells if the 
Leptospira were pre-treated with Fn. These results support 
the recent report that Fn might be an important molecule 
involved in the pathogenic adherence of Leptospira spp. to 
host cells [6,24]. 
  We demonstrated the interaction between LigB and Fn. It 
was shown that the LigBCen and LigBCtv fragments were 
bound to Fn, by GST-pulldown assays, ELISA and ITC 
measurements. The low Kd values for LigBCen indicated 
that the LigB-Fn interaction was specific. This evidence 
strongly suggests that LigB is a Fn-binding protein. A 
study reported by Choy et al. [6] showed that LigB U1 and 
LigB U2 (LigBCen equivalent) could strongly bind to Fn, 
while the LigB CTD (LigBCtv equivalent) binds weakly to 
Fn. However, the Kd values of LigBCen and LigBCtv to Fn 
that we obtained were slightly different than those reported 
by Choy et al. [6]. The differences in the obtained Kd val-
ues could be explained by (i) the protein fragments eval-
uated in this study (LigBCen and LigBCtv) were not ex-
actly the same length fragments (LigBU1, LigBU2 and 
LigBCTD) and (ii) the method we used (ITC) to measure 
the Kd differed from that of Choy et al. [6].
  Since pathogenic Leptospira spp. adheres to renal tubular 
epithelial cells and induces a severe tubulointerstitial 
nephritis leading to renal failure [58], it is possible that 
LigB is responsible for the binding of Leptospira to the re-
nal tubular epithelium. Our results indicated that LigB 
binds to the MDCK cells via the LigBCen or the LigBCtv 
fragments. However, the LigBCen was observed to bind to 
both the MDCK cells and Fn with a greater affinity than the 
LigBCtv. The microscopic images also showed that not all 
of the Fn was co-localized with the LigB. This result sug-
gests that LigB might bind to two or more receptors. Our 
results elucidate the process of Leptospira attachment to 
the MDCK cells, as noted in a previous study [52], and 
demonstrated how Fn can block leptospiral attachment to 
the MDCK cells. 
  Our results clearly confirm that LigB is one of the micro-
bial surface components that recognize adhesive matrix 
molecules (MSCRAMM) members that bind to the ECM 
including Fn. The transmembrane domain of LigB is pre-
dicted to reside within the conserved region, with only the 
variable region exposed on the surface [33,34]. These re-
sults support our data that Fn-binding domains of LigB are 
localized in the variable regions. This is not surprising 
since similar findings have been reported for other 
MSCRAMMs [13,37,39]. In Borrelia, the binding motifs 
in the decorin-binding proteins, DbpA and B, are located in 
the central regions, which vary among the different 
Borrelia strains (B. burgdorferi, B. garnii, and B. afzeli) 
[37]. The Fn-binding domain of the Fn-binding protein, 
BBK32 is also variable among the different Borrelia 
strains [39]. The repetitive D1, D2 and D3 elements of 
Staphylococcus aureus Fn-binding protein, which bind the 
N-terminal 29 kDa of Fn, also vary [13]. 
  Since both LigBCen and LigBCtv bind to Fn, but with dif-
ferent affinities, this suggests that there is more than one 
potential Fn-binding domain. In Mycobacterium avium, 
two Fn-binding domains are located on two non-con-
tiguous segments of 24 amino acids in the Fn attachment 
protein-A [45]. The FnBPA of Staphylococcus aureus con-
tains three repetitive elements, D1, D2 and D3 and each 
binds the N-terminal 29 kDa fragment of Fn [13]. Seven 
additional Fn-binding elements are located in the N-termi-
nal of the D repeats [48]. In Streptococcus dysgalactiae, 
there are five Fn-binding segments within the C-terminus 
of the Fn binding protein F1/(FnBB) [47,48]. Therefore, it 
is likely that several binding sites might be present in the 
LigB variable region. However, we were unable to identify 
a similar Fn-binding motif in the other known Fn-binding 
proteins. 
  In conclusion, we have shown that LigBCen and LigBCtv 
bind to Fn and have confirmed that LigB is a member of the 
MSCRAMMs. Since pathogenic Leptospira spp. initially 
attaches to mucosal epithelial cells prior to entry into the 
bloodstream and subsequent dissemination to multiple or-
gans such as the kidney, liver and lung, Lig proteins may 
play a pivotal role in the pathogenesis of leptospirosis. Fn 
is one of the most important ECMs on epithelial cells and 
serves as a receptor for leptospiral adherence [6,15,24]. 
Thus, further studies into the interaction of Lig proteins 
and ECMs are warranted. 
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